YXYao Xiao

Yao Xiao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yao Xiao has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • Chao Zhang

    Department of Neurosurgery, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, China

    1 shared publication
  • Fan Xiao

    Department of Respiratory and Critical Care Medicine Sir Run Run Shaw Hospital Zhejiang University School of Medicine Hangzhou Zhejiang P. R. China

    1 shared publication
  • Haoxiang Chen

    Department of Neurosurgery, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, P.R. China

    1 shared publication
  • Honghui Cai

    Department of Neurosurgery, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, P.R. China

    1 shared publication
  • Jinyue Fan

    Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, P.R. China

    1 shared publication
  • Lingyan Lu

    Department of Neurosurgery, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, P.R. China

    1 shared publication

Latest Publications

  • Open Access

    DNA Nanotechnology-Enabled Precise Regulation of Nanozymes and Their Applications

    by Zishuo Liu, Yuanbo Zhao, Haoxiang Chen, Xin Fu, Jinyue Fan, Lingyan Lu, Zhiwen Lyu, Honghui Cai, Ziming Wang, Chao Zhang, et al.

    Nanozymes overcome key limitations of natural enzymes, including poor environmental tolerance, high production costs, and batch-to-batch variability, with their enhanced physicochemical stability and controllable catalytic performance, thus enabling applications in biocatalysis and disease theranostics. However, their practical applications remain limited by insufficient catalytic efficiency, inadequate target specificity, and restricted programmable dynamic adaptability. DNA nanotechnology offers a versatile and biocompatible framework for the precise regulation of nanozymes due to its sequence-defined programmability and precise molecular recognition capability. This approach improves catalytic performance while maintaining excellent biocompatibility and low immunogenicity. This review systematically summarizes the latest advances in DNA nanotechnology-mediated precise regulation of nanozymes, with particular emphasis on the mechanistic basis of 6 regulatory modes. We further examine the representative applications of these DNA–nanozyme hybrid systems in disease therapy, biomedical sensing, and environmental monitoring, and outline the key challenges and future directions toward clinical and industrial translation.